Andersson et al. Nature Communications 2017 describe the validation of thirteen commercial and academic antibodies raised against estrogen receptor beta (ERbeta).
The present antibody proved excellent for IHC (1:600 dilution), Western blotting and IP as determined by comparing results from ERbeta positive cells and ERbeta negative cells.
The antibody is also available from Invitrogen and R&D Systems.
See data figure and link to full article above.
On August 2, 2017 Cecilia Williams, KTH Royal Institute of Technology, Sweden wrote:
Andersson et al. Nature Communications 2017 describe the validation of thirteen commercial and academic antibodies raised against estrogen receptor beta (ERbeta).
The present antibody proved excellent for IHC (1:600 dilution), Western blotting and IP as determined by comparing results from ERbeta positive cells and ERbeta negative cells.
The antibody is also available from Invitrogen and R&D Systems.
See data figure and link to full article above.